POSTN and colorectal cancer: The high expression level of the POSTN gene was repeatedly reported to correlate with poor outcome of different human malignancies, which include shorter progression-free survival following first-line chemotherapy in epithelial ovarian cancer [34], more advanced stage and lower survival rates in colorectal cancer patients [35], and high grade and invasive meningioma [36].